Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.

No abstract is available for this paper.

• Publication year

  1975

• Venue

  Journal of Clinical Investigation

• Publication date

  1975-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI107967PMID 123251PMCID PMC301788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of Polaroid Land film in radioautography.

  1974cited by this paper
• FOURTH COMPONENT OF HUMAN COMPLEMENT: DESCRIPTION OF A THREE POLYPEPTIDE CHAIN STRUCTURE

  1974cited by this paper
• Isolation and characterization of the proenzyme form of the C1s subunit of the first complement component.

  1974cited by this paper
• Mechanism of action of naturally occurring proteinase inhibitors. Studies with anhydrotrypsin and anhydrochymotrypsin purified by affinity chromatography.

  1974cited by this paper
• Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.

  1973cited by this paper
• The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism

  1973cited by this paper
• Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.

  1973cited by this paper
• STUDIES ON HUMAN PLASMA α2-MACROGLOBULIN-ENZYME INTERACTIONS

  1973cited by this paper
• The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

  1973cited by this paper
• Measurement of molecular weights by electrophoresis on SDS-acrylamide gel.

  1972cited by this paper
• Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids.

  1972cited by this paper
• Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.

  1972cited by this paper
• Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

  1971cited by this paper
• The Non-Bond Splitting Mechanism of Action of Inhibitors of Proteolytic Enzymes — the Conservative Interpretation

  1971cited by this paper
• C1 inactivator inhibition by plasmin.

  1970cited by this paper
• Ein Beitrag zur Isolierung und Charakterisierung des C‐Inaktivators aus Humanplasma

  1970cited by this paper
• Plasminogen: Purification from Human Plasma by Affinity Chromatography

  1970cited by this paper
• A sensitive colorimetric method for the measurement of serum C1 inactivator using the substrate N-alpha-acetyl-L-lysine methyl ester.

  1970cited by this paper
• HUMAN PLASMA ALPHA 2-MACROGLOBULIN

  1970cited by this paper
• Interaction of plasma kallikrein with the C1 inhibitor.

  1970cited by this paper
• Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.

  1970cited by this paper
• Group-specific adsorption of glycoproteins.

  1970cited by this paper
• [Isolation and characterization of C1-Inactivator from human plasma].

  1970cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR

  1969cited by this paper
• Subunit structure of myosin. 3. A proposed model for rabbit skeletal myosin.

  1969cited by this paper
• Glycoprotein staining following electrophoresis on acrylamide gels.

  1969cited by this paper
• Inhibition of Hageman factor activation.

  1968cited by this paper
• The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.

  1968cited by this paper
• A comparison of methods for the molecular quantitation of the fourth component of human complement.

  1968cited by this paper
• The isolation and characterization of the S-carboxymethyl beta (light) chain derivative of human plasmin. The localization of the active site on the beta (light) chain.

  1967cited by this paper
• Inhibition of plasmin activity by alpha-2-macroglobulin.

  1967cited by this paper
• The specific mechanism of activation of human plasminogen to plasmin.

  1967cited by this paper
• ENHANCEMENT OF THE HEMOLYTIC ACTIVITY OF THE SECOND COMPONENT OF HUMAN COMPLEMENT BY OXIDATION

  1967cited by this paper
• Inhibition of plasmin activity by α2-macroglobulin

  1967cited by this paper
• A method of trace iodination of proteins for immunologic studies.

  1966cited by this paper
• Dissociation of Esterolytic and Clotting Activities of Thrombin by Trypsin-Binding Macroglobulin.∗

  1966cited by this paper
• ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

  1965cited by this paper
• Interaction of a serum inhibitor of C'I-esterase with intermediate complexes of the immune haemolytic system. I. Specificity of inhibition of C'I activity associated with intermediate complexes.

  1962cited by this paper
• Partial purification of a serum inhibitor of C'1-esterase.

  1961cited by this paper
• A new supporting medium for preparative electrophoresis.

  1960cited by this paper
• xi-Aminocaproic acid: an inhibitor of plasminogen activation.

  1959cited by this paper
• Assay and Properties of Serum Inhibitor of C'1-Esterase∗

  1959cited by this paper
• Une micro-méthode de l’immuno-électrophorèse

  1955cited by this paper
• [A micro-method of immuno-electrophoresis].

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies

  2025cites this paper
• Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.

  2025cites this paper
• The complement system in human pregnancy and preeclampsia

  2025cites this paper
• Genital Attacks in Hereditary Angioedema and Their Effects on Sexual Life

  2024cites this paper
• Increased thromboinflammatory load in hereditary angioedema

  2023cites this paper
• Complement system in Anti-CD20 mAb therapy for cancer: A mini-review

  2023cites this paper
• Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis

  2022cites this paper
• Factor VII activating protease (FSAP) is not essential in the pathophysiology of angioedema in patients with C1 inhibitor deficiency.

  2021cites this paper
• C1-Inhibitor: Structure, Functional Diversity and Therapeutic Development.

  2021cites this paper
• Anti-C1-Inhibitor Autoantibody Detection by ELISA.

  2021cites this paper
• Exploration of Serum Marker Proteins in Mice Induced by Babesia microti Infection Using a Quantitative Proteomic Approach

  2021cites this paper
• Assessing Plasmin Generation in Health and Disease

  2021cites this paper
• Complement System

  2020cites this paper
• Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients

  2020cites this paper
• Management of patients with hereditary angio-oedema in dental, oral, and maxillofacial surgery: a review.

  2019cites this paper
• α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism

  2018cites this paper
• Hereditary angioedema: the plasma contact system out of control

  2018cites this paper
• Assay for Cl Inhibitor in Human Plasma

  2017cites this paper
• An integrated top-down and bottom-upproteomic platform to reveal potential salivarybiomarkers of the rare disorders SAPHOsyndrome, Wilson’s disease and Hereditaryangioedema

  2016cites this paper
• The Regulatory Activities of recombinant Properdin and TSP1 on Platelet and Complement activation

  2016cites this paper
• Deficiencies of the Complement System

  2014cites this paper
• Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base.

  2014cites this paper
• The role of coagulation factor XII in fibrin clot formation and fibrinolysis

  2014cites this paper
• inhibitor by synthetic fibrinolytic agents Inactivation of purified human alpha 2-antiplasmin and purified human C1

  2013cites this paper
• Alterations of coagulation and fibrinolysis in patients with angioedema due to C1‐inhibitor deficiency

  2012cites this paper
• Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits.

  2012cites this paper
• Interaction of C1 inhibitor with thrombin on the endothelial surface

  2011cites this paper
• C1-Inhibitor: More Than a Serine Protease Inhibitor

  2011cites this paper
• Complement inhibition accelerates regeneration in a model of peripheral nerve injury.

  2009cites this paper
• Kallikrein inhibitors 1

  2009cites this paper
• Disassembly intermediates of RbsD protein remain oligomeric despite the loss of an intact secondary structure

  2009cites this paper
• Molecular Details of Serum Resistance of Yersinia enterocolitica

  2008cites this paper
• The complement system in the peripheral nerve

  2008cites this paper
• Soluble complement receptor 1 (sCR1) protects the peripheral nerve from early axon loss after injury

  2008cites this paper
• Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury.

  2008cites this paper
• Biological activities of C1 inhibitor.

  2008cites this paper
• Blood inhibitory capacity toward exogenous plasmin

  2007cites this paper
• The Membrane Attack Complex of the Complement System Is Essential for Rapid Wallerian Degeneration

  2007influential citation
• The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema

  2007cites this paper
• Rheumatoid arthritis and the complement system

  2007cites this paper
• Mechanism of angioedema in first complement component inhibitor deficiency.

  2006cites this paper
• C1 inhibitor: molecular and clinical aspects

  2005cites this paper
• The Effect ofCl Inhibitor Upon Hageman Factor

  2005cites this paper
• Biochemical and Functional Studies of a Novel Complement Inhibitor, CRIT, with Its Interaction Partners

  2005cites this paper
• Complement C2 Receptor Inhibitor Trispanning: A Novel Human Complement Inhibitory Receptor12

  2005influential citation
• Biochemical and functional studies of a novel complement inhibitor, CRIT, with its interaction partners

  2005cites this paper
• Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s.

  2005cites this paper
• The first component of human complement (C1): Activation and control

  2004cites this paper
• The biological role of the C1 inhibitor in regulation of vascular permeability and modulation of inflammation.

  2004cites this paper
• Interactions of soluble complement regulators with pathogenic bacteria

  2004cites this paper
• Bradykinin and the pathophysiology of angioedema.

  2003cites this paper
• ISOLATION AND ANALYSIS OF THE MECHANISM OF ACTION OF AN INACTIVATOR OF C4b IN NORMAL HUMAN SERUM*

  2003cites this paper
• Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood.

  2003cites this paper
• Effect of various forms of the C1 esterase inhibitor (C1‐INH) and DAF on complement mediated xenogeneic cell lysis

  2003cites this paper
• The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism

  2002influential citation
• Attempts to Prepare Suitable Complement Regulatory Molecules for Clinical Xenotransplantation

  2001cites this paper
• In vitro interaction of C1-inhibitor with thrombin

  2001cites this paper
• Serpins (Serine Protease Inhibitors)

  2001influential citation
• Microheterogeneous changes of the C1-esterase inhibitor in plasma cannot predict operability, postoperative complications, or recurrence in cancer surgery.

  2001cites this paper
• Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway

  2001cites this paper
• C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.

  2000cites this paper
• Genetics of the complement system.

  2000cites this paper
• Evaluation of Complement Inhibitors

  2000cites this paper
• A surface-bound form of human C1 esterase inhibitor on xenografts: the complement regulatory function.

  2000cites this paper
• A surface-bound form of human C1 esterase inhibitor improves xenograft rejection.

  2000cites this paper
• C1 Inhibitor Cross-linking by Tissue Transglutaminase*

  2000cites this paper
• Activation of the Contact System in Cerebrospinal Fluid of Patients with Alzheimer Disease

  1998cites this paper
• C1 Inhibitor Gene and Hereditary Angioedema

  1998cites this paper
• Regulation of C1 inhibitor synthesis.

  1998cites this paper
• C1 inhibitor. Functional analysis of naturally-occurring mutant proteins.

  1997cites this paper
• Chemistry and Biology of Serpins

  1997cites this paper
• Degradation ofCl-Inhibitor by Plasmin: Implications fortheControl ofInflammatory Processes

  1997cites this paper
• C1 inhibitor. Functional analysis of naturally-occurring mutant proteins.

  1997cites this paper
• Role of the distal hinge region of C1‐inhibitor in the regulation of C1s activity

  1997cites this paper
• Kinin generation in acute pneumonia and chronic bronchitis.

  1997cites this paper
• Degradation of C1-Inhibitor by Plasmin: Implications for the Control of Inflammatory Processes

  1997cites this paper
• Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8.

  1996cites this paper
• A solid-phase antibody capture assay for the measurement of C1-inhibitor consumption in vivo.

  1996cites this paper
• Autoimmune C1‐inhibitor deficiency

  1996cites this paper
• Structural basis for serpin inhibitor activity

  1995cites this paper
• The complement system and inflammation

  1995cites this paper
• COOH-terminal Substitutions in the Serpin C1 Inhibitor That Cause Loop Overinsertion and Subsequent Multimerization (*)

  1995cites this paper
• Factor J, a human inhibitor of complement C1, is a cationic, highly glycosylated protein.

  1994cites this paper
• From Localized Angioedema to Generalized Capillary Leak Syndrome: Evidence for a Pivotal Role of C1-Inhibitor in Septic Shock-like Syndromes

  1994cites this paper
• Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.

  1994cites this paper
• Large-scale preparation of highly purified human C1-inhibitor for therapeutic use.

  1994cites this paper
• Serpins Are Suicide Substrates: Implications for the Regulation of Proteolytic Pathways

  1994cites this paper
• Plasmin and thrombin inhibitors in essentially untreated patients with coronary artery spasm.

  1993cites this paper
• Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.

  1993cites this paper
• Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3

  1993cites this paper
• Spa bathing activates fibrinolysis in patients with cerebral infarction.

  1993cites this paper
• Generation of plasmin during acute attacks of hereditary angioedema.

  1993cites this paper
• C1-inhibitor and its genetic alterations in hereditary angioneurotic edema.

  1993cites this paper
• Genetically determined deficiences of the complement system

  1992cites this paper
• Characterization of recombinant C1 inhibitor P1 variants.

  1992cites this paper
• Fat‐storing cells of the rat liver synthesize and secrete C1‐esterase inhibitor; modulation by cytokines

  1992cites this paper
• C1 INHIBITOR: STRUCTURE, GENETIC VARIANTS AND SERPIN HOMOLOGIES

  1991cites this paper
• C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema.

  1991cites this paper
• Hepatologie Neuere Forschungsergebnisse in ihrer Bedeutung für das Verständnis von Leberkrankheiten

  1991cites this paper
• [Hepatology. New research results in its significance for the understanding of liver diseases].

  1991cites this paper